Single-cell analysis uncovers that metabolic reprogramming by ErbB2 signaling is essential for cardiomyocyte proliferation in the regenerating heart

  1. Hessel Honkoop
  2. Dennis EM de Bakker
  3. Alla Aharonov
  4. Fabian Kruse
  5. Avraham Shakked
  6. Phong D Nguyen
  7. Cecilia de Heus
  8. Laurence Garric
  9. Mauro J Muraro
  10. Adam Shoffner
  11. Federico Tessadori
  12. Joshua Craiger Peterson
  13. Wendy Noort
  14. Alberto Bertozzi
  15. Gilbert Weidinger
  16. George Posthuma
  17. Dominic Grun
  18. Willem J van der Laarse
  19. Judith Klumperman
  20. Richard T Jaspers
  21. Kenneth D Poss
  22. Alexander van Oudenaarden
  23. Eldad Tzahor
  24. Jeroen Bakkers  Is a corresponding author
  1. Hubrecht Institute, Netherlands
  2. Weizmann Institute of Science, Israel
  3. University Medical Center Utrecht, Netherlands
  4. Duke University Medical Center, United States
  5. Vrije Universiteit Amsterdam, Netherlands
  6. Ulm University, Germany
  7. Max Planck Institute for Immunbiology and Epigenetics, Germany
  8. VU University Medical Center, Netherlands

Abstract

While the heart regenerates poorly in mammals, efficient heart regeneration occurs in zebrafish. Studies in zebrafish have resulted in a model in which preexisting cardiomyocytes dedifferentiate and reinitiate proliferation to replace the lost myocardium. To identify which processes occur in proliferating cardiomyocytes we have used a single-cell RNA-sequencing approach. We uncovered that proliferating border zone cardiomyocytes have very distinct transcriptomes compared to the nonproliferating remote cardiomyocytes and that they resemble embryonic cardiomyocytes. Moreover, these cells have reduced expression of mitochondrial genes and reduced mitochondrial activity, while glycolysis gene expression and glucose uptake are increased, indicative for metabolic reprogramming. Furthermore, we find that the metabolic reprogramming of border zone cardiomyocytes is induced by Nrg1/ErbB2 signaling and is important for their proliferation. This mechanism is conserved in murine hearts in which cardiomyocyte proliferation is induced by activating ErbB2 signaling. Together these results demonstrate that glycolysis regulates cardiomyocyte proliferation during heart regeneration.

Data availability

Sequencing data have been deposited in GEO under accession code GSE139218Other data generated during this study are included in the manuscript and supporting files

The following data sets were generated

Article and author information

Author details

  1. Hessel Honkoop

    Cardiac Development and Genetics, Hubrecht Institute, Utrecht, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  2. Dennis EM de Bakker

    Cardiac Development and Genetics, Hubrecht Institute, Utrecht, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  3. Alla Aharonov

    Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
    Competing interests
    The authors declare that no competing interests exist.
  4. Fabian Kruse

    Cardiac Development and Genetics, Hubrecht Institute, Utrecht, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  5. Avraham Shakked

    Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
    Competing interests
    The authors declare that no competing interests exist.
  6. Phong D Nguyen

    Cardiac Development and Genetics, Hubrecht Institute, Utrecht, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  7. Cecilia de Heus

    Department of Cell Biology, University Medical Center Utrecht, Utrecht, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  8. Laurence Garric

    Cardiac Development and Genetics, Hubrecht Institute, Utrecht, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  9. Mauro J Muraro

    Hubrecht Institute, Hubrecht Institute, Utrecht, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  10. Adam Shoffner

    Department of Cell Biology, Duke University Medical Center, Durham, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Federico Tessadori

    Cardiac Development and Genetics, Hubrecht Institute, Utrecht, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  12. Joshua Craiger Peterson

    Department of Human Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  13. Wendy Noort

    Department of Human Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  14. Alberto Bertozzi

    Institute of Biochemistry and Molecular Biology, Ulm University, Ulm, Germany
    Competing interests
    The authors declare that no competing interests exist.
  15. Gilbert Weidinger

    Institute of Biochemistry and Molecular Biology, Ulm University, Ulm, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3599-6760
  16. George Posthuma

    Department of Cell Biology, University Medical Center Utrecht, Utrecht, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  17. Dominic Grun

    Max Planck Institute for Immunbiology and Epigenetics, Freiburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  18. Willem J van der Laarse

    Department of Physiology, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  19. Judith Klumperman

    Department of Cell Biology, University Medical Center Utrecht, Utrecht, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  20. Richard T Jaspers

    Department of Human Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6951-0952
  21. Kenneth D Poss

    Regeneration Next, Department of Cell Biology, Duke University Medical Center, Durham, United States
    Competing interests
    The authors declare that no competing interests exist.
  22. Alexander van Oudenaarden

    Hubrecht Institute, Hubrecht Institute, Utrecht, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  23. Eldad Tzahor

    Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5212-9426
  24. Jeroen Bakkers

    Cardiac Development and Genetics, Hubrecht Institute, Utrecht, Netherlands
    For correspondence
    j.bakkers@hubrecht.eu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9418-0422

Funding

ERA-CVD (JCT2016-40-080)

  • Gilbert Weidinger
  • Eldad Tzahor
  • Jeroen Bakkers

NIH Clinical Center (R01 HL131319)

  • Kenneth D Poss

NIH Clinical Center (R01 HL136182)

  • Kenneth D Poss

Deutsche Forschungsgemeinschaft (251293561)

  • Gilbert Weidinger

Netherlands Heart Foundation NHS/CVON (Cobra3)

  • Jeroen Bakkers

European Molecular Biology Organization (ALTF1129-2015)

  • Phong D Nguyen

Human Frontier Science Program (LT001404/2017-L)

  • Phong D Nguyen

Dutch Research Council (016.186.017-3)

  • Phong D Nguyen

Deutsche Forschungsgemeinschaft (316249678)

  • Gilbert Weidinger

Deutsche Forschungsgemeinschaft (414077062)

  • Gilbert Weidinger

NIH Clinical Center (RO1 HL081674)

  • Kenneth D Poss

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All experiments were conducted in accordance with the ethical guidelines. Animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of the Royal Dutch Academy of Sciences (AVD801002016404), the state of Baden-Württemberg and the animal protection representative of Ulm University (Tierversuch 1352), Duke University (A057-18-02) and the Weizmann Institute (13240419-3).

Copyright

© 2019, Honkoop et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 12,486
    views
  • 1,798
    downloads
  • 171
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Hessel Honkoop
  2. Dennis EM de Bakker
  3. Alla Aharonov
  4. Fabian Kruse
  5. Avraham Shakked
  6. Phong D Nguyen
  7. Cecilia de Heus
  8. Laurence Garric
  9. Mauro J Muraro
  10. Adam Shoffner
  11. Federico Tessadori
  12. Joshua Craiger Peterson
  13. Wendy Noort
  14. Alberto Bertozzi
  15. Gilbert Weidinger
  16. George Posthuma
  17. Dominic Grun
  18. Willem J van der Laarse
  19. Judith Klumperman
  20. Richard T Jaspers
  21. Kenneth D Poss
  22. Alexander van Oudenaarden
  23. Eldad Tzahor
  24. Jeroen Bakkers
(2019)
Single-cell analysis uncovers that metabolic reprogramming by ErbB2 signaling is essential for cardiomyocyte proliferation in the regenerating heart
eLife 8:e50163.
https://doi.org/10.7554/eLife.50163

Share this article

https://doi.org/10.7554/eLife.50163

Further reading

    1. Developmental Biology
    Megan L Martik
    Insight

    Experiments in zebrafish have shed new light on the relationship between development and regeneration in the heart.

    1. Chromosomes and Gene Expression
    2. Developmental Biology
    Leif Benner, Savannah Muron ... Brian Oliver
    Research Article

    Differentiation of female germline stem cells into a mature oocyte includes the expression of RNAs and proteins that drive early embryonic development in Drosophila. We have little insight into what activates the expression of these maternal factors. One candidate is the zinc-finger protein OVO. OVO is required for female germline viability and has been shown to positively regulate its own expression, as well as a downstream target, ovarian tumor, by binding to the transcriptional start site (TSS). To find additional OVO targets in the female germline and further elucidate OVO’s role in oocyte development, we performed ChIP-seq to determine genome-wide OVO occupancy, as well as RNA-seq comparing hypomorphic and wild type rescue ovo alleles. OVO preferentially binds in close proximity to target TSSs genome-wide, is associated with open chromatin, transcriptionally active histone marks, and OVO-dependent expression. Motif enrichment analysis on OVO ChIP peaks identified a 5’-TAACNGT-3’ OVO DNA binding motif spatially enriched near TSSs. However, the OVO DNA binding motif does not exhibit precise motif spacing relative to the TSS characteristic of RNA polymerase II complex binding core promoter elements. Integrated genomics analysis showed that 525 genes that are bound and increase in expression downstream of OVO are known to be essential maternally expressed genes. These include genes involved in anterior/posterior/germ plasm specification (bcd, exu, swa, osk, nos, aub, pgc, gcl), egg activation (png, plu, gnu, wisp, C(3)g, mtrm), translational regulation (cup, orb, bru1, me31B), and vitelline membrane formation (fs(1)N, fs(1)M3, clos). This suggests that OVO is a master transcriptional regulator of oocyte development and is responsible for the expression of structural components of the egg as well as maternally provided RNAs that are required for early embryonic development.